Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
13th ed
AZ did show a peak in filings between 2013 and 2014 following the acquisition, however, the number of filings appears to have dropped off since then
Efficacy and safety Beyond its primary use for type 2 diabetes, tirzepatide has been explored for its potential in treating obesity, osteoarthritis of the knee, atherosclerosis, and other metabolic diseases
Growth performance G3 and G4 showed a marked increase in final weight, feed intake, weight gain, feed efficiency, and a marked lower feed conversion ratio, while reverse results were observed in G2 compared to G1
US$ 21.67
US$ 22.25
US$ 24.23
US$ 26.11
